The Svandis ecosystem is driven by a community of users and researchers using powerful Svandis tools, analytics, and indicators for professional traders in need of real-time, actionable data and analyses. The Svandis community drives the rapid collection of verifiable data and information through a tokenized incentive system. The platform within the ecosystem provides leading financial research, analytical and visualisation tools for anyone actively involved in the space: short-term and swing traders, traditional holders, analysts, hedge funds, institutional investors, trading firms, and token sale contributors.

CARE Token is an ethereum blockchain cryptocurrency project that based on senior health care services. The project have backing of a known health care company in Nigeria called A&A Elderly Care Services.The project aim to provide solutions to the threat posing a challenge towards the care of the seniors through our DApp Platform.

KardiaChain is the blockchain of blockchains. A scalable and interoperable blockchain platform for decentralized applications. Our Vision: We believe Blockchain can create equal opportunities for people, a world where people have access to opportunity to invest, to start a business, to work and to be socially mobile. Our technology empowers mass adoption, expand use-cases and lay foundation of the blockchain ecosystem. We are building a blockchain platform for decentralised applications helping to create a blockchain ecosystem that allows for scaling and connecting disparate blockchains. Our Core Technology is: - Dual Node - Elastic Sharding With Incentive Mechanism (ESWIM) - Kardia Smart Contract Markup Language (KSML) Our Use cases are: - Supply Chain Management - Fully Decentralised Cross-chain Exchange - Smart City

Ispolink is cutting-edge automated matchmaking job board platform that leverages Blockchain and Artificial Intelligence (AI) technology to address one of the most fundamental challenges that exist nowadays – sourcing and attracting qualified personnel. We strive to empower companies operating in the blockchain and IT domain to fill their positions by providing them a full spectrum of tools to conduct and manage in-house the entire recruitment process efficiently - ranging from candidate sourcing, screening, through the various stages of interviews until the final offer, eliminating the need of intermediaries such as HR agencies. As per the job seekers, the platform is tailored to improve their overall experience by reducing the prolonged job searching, the endless waiting for feedback, coupled with convenience to receive the best offers with only a few clicks. Ispolink’s blockchain based product facilitates the processes for filling roles by providing a full cycle recruitment system. The platform will make the entire recruitment process more transparent, optimized, automated and also to help organizations to enhance their internal communication which will result in substantial cost and time reductions

Vidy is the world's first decentralized ad network, powered by the ethereum blockchain. Vidy's ad platform allows advertisers to embed video ads directly into hyper-relevant website text, improving user experience, ad conversions and publisher payments. With just a hold, users can now reveal tiny hyper-relevant videos embedded in the text of any page on the web, unlocking a whole new dimension of the internet. All ads are placed with an NLP consensus protocol driven by miners. With a team of veteran engineers, industry-leading advisors and world-class brand partners, Vidy is on it's way to reinventing online advertising, e-commerce, and entertainment.

MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.